为了优化社区脆弱性指数对COVID-19流行率的优化
Lung-Chang Chien1, L-W Antony Chen2, Chad L Cross1
1Department of Epidemiology and Biostatistics, University of Nevada Las Vegas, Las Vegas, NV, USA.
BMC public health
|April 29, 2025
概括
为了更好地评估COVID-19风险,开发了一种新的社区脆弱性指数 (CVI),其表现优于CDC的社会脆弱性指数. CVI为有针对性的公共卫生干预提供了人口特异性的洞察力.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 健康的社会决定因素
背景情况:
- 疾病预防控制中心的社会脆弱性指数 (SVI) 可能无法充分捕捉不同社区的COVID-19风险.
- 评估健康差异需要根据特定的人口和社区特征量身定制的指数.
- 克拉克县,内华达州,为评估社区层面的脆弱性提供了一个独特的人口格局.
研究的目的:
- 开发和验证一个针对人口特异性COVID-19流行率进行优化的社区脆弱性指数 (CVI).
- 将CVI应用于内华达州克拉克县的人口普查区级别.
- 确定影响不同亚群体COVID-19风险的关键社会和社区因素.
主要方法:
- 使用15个SVI变量和8个额外的社区变量 (例如住房,通勤,密度) 构建了CVI.
- 使用加权定量总和 (WQS) 回归与引导将23个变量与COVID-19病例联系起来 (2020年1月至2021年11月).
- 产生了一个全人口的CVI和13个人口特异性的CVI (年龄,种族,性别).
主要成果:
- 在所有模型中,WQS回归证实了CVI和COVID-19流行率之间的显著关联.
- 全人口CVI的关键预测因素包括少数群体地位,公园剥夺,年轻年龄,不活跃的通勤和住房不足.
- 亚种群的CVI显示出不同的空间差异,女性,白人和老年人 (50-64岁) 群体的显著差异.
结论:
- 开发的CVI提供了一种实用,可适应的方法,用于在细粒度层面评估COVID-19风险.
- 人口特异性和包含额外的社区变量增强了CVI的实用性.
- CVI可以为基于证据的政策和针对弱势群体的有针对性的干预提供信息.
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
236
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
236
Prevalence and Incidence
255
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
255
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
27
Flood risk assessment involves careful planning and analysis to ensure the safety of communities near water retention structures. Capacity contours are a vital tool in this process, as they illustrate the potential spread of water at specific levels in a given area. In the context of building a bund across a small valley, these contours play a critical role in evaluating the safety of nearby residential areas.In this example, the bund is intended to store stormwater in the valley. The engineers...
27
Bias in Epidemiological Studies
92
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
92
Causality in Epidemiology
154
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
154
Hazard Ratio
64
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
64


